Cormack-Aboud, Fionnuala C <br/><br/>
Rosuvastatin protects against podocyte apoptosis in vitro.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Feb 2009 
 - 404-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfn528  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Cell Survival--drug effects<br/>Cells, Cultured<br/>Cyclin-Dependent Kinase Inhibitor p21--deficiency<br/>Doxorubicin--toxicity<br/>Fluorobenzenes--pharmacology<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Mice<br/>Mice, Knockout<br/>Podocytes--cytology<br/>Proteinuria--prevention & control<br/>Puromycin Aminonucleoside--toxicity<br/>Pyrimidines--pharmacology<br/>Recombinant Proteins--genetics<br/>Rosuvastatin Calcium<br/>Sulfonamides--pharmacology<br/>Transduction, Genetic